We thank Dr Geller for his letter regarding our recent article.1 In his letter, Dr Geller suggests that clinicians appropriately reject evidence-based guidelines for LBP because (1) the use of paracetamol poses an unacceptably high risk of adverse events compared with NSAIDs and (2) opioids have some benefit in disease progression.
Williams CM, Maher CG, Hancock MJ, McLachlan AJ, McAuley JH, Latimer J. Appropriate Discard of “Best” Practice Guidelines for Acute Low Back Pain—Reply. Arch Intern Med. 2010;170(12):1087-1088. doi:10.1001/archinternmed.2010.191